PHARMACEUTICAL COMPOSITION OF ENTACAPONE, LEVODOPA AND CARBIDOPA WITH IMPROVED BIOAVAILABILITY

• 收藏
• 分享

专利权人:

发明人:

TALWAR MUNISH,KAPOOR RITESH,MASHALKAR MANOJ,JAIN GIRISH KUMAR

申请号：

IN263/MUM/2008

公开号：

IN259826B

申请日:

2008.02.06

申请国别(地区):

IN

年份:

2014

代理人:

摘要：

The invention provides a signal oral dose pharmaceutical composition comprising, triple combination of entacepone, levodapa and carbidopa, or salts thereof along with one or more sugar alcohols wherein entacapone is co-micronized with sugar alcohol, characterized in that one or both of the rate and the absorption of composition comprising triple combination of entacepone, levodapa and carbidopa, or salts thereof is equal to or greater than that obtained by a triple combination of entacepone, levodapa and carbidopa formulation markted under the trade name Stalevo200(R).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/